Clinical trial
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
NCT01972568 is registered in ClinicalTrials.gov with EMD Serono as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
- Lead sponsor
- EMD Serono
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 31, 2013
- Completion date
- September 30, 2016
- Enrollment
- 306 (actual)
- Sites
- 138
Conditions
As the registry lists them; a condition with its own page is linked.